AI summary by TwinMind
How Cannabis Impacts Health & the Potential Risks | Dr. Matthew Hill
Andrew Huberman
3h 52m 38s
Introduction and Cannabis Basics
- Dr. Matthew Hill: Professor of Cell Biology and Anatomy at University of Calgary
- Studies cannabis effects on stress, feeding, and behavioral impacts across development
- Cannabis contains 70+ cannabinoids, THC is primary psychoactive compound
- CBD is second major component but non-intoxicating
- Terpenes contribute to smell/flavor, may influence effects but unclear
- "Entourage effect" theory suggests combined molecules work differently than isolated THC
Endocannabinoid System Biology
- CB1 receptors most widely expressed in brain (except brainstem cardiorespiratory areas)
- CB2 receptors mainly on immune cells, regulate inflammation
- Endocannabinoids work retrograde (backwards) across synapses
- Two main endocannabinoids:
- Anandamide: high affinity, low efficacy, "tonic" regulator
- 2-AG: lower affinity, high efficacy, "phasic" on-demand molecule
- Primary role: maintain homeostasis, prevent runaway excitation/inhibition
- Dopamine neurons uniquely lack CB1 receptors
THC vs Endocannabinoids
- THC acts as partial agonist at CB1, high affinity but lower efficacy than 2-AG
- Key difference: THC "carpet bombs" all CB1 receptors simultaneously
- Endocannabinoids released spatially/temporally specific
- Elevating anandamide via enzyme inhibition produces no psychoactive effects
- THC intoxication likely due to widespread simultaneous network disruption
Routes of Administration and Dosing
- Smoking/vaping: 2-5 minute onset, peak 15-30 minutes, duration 2-4 hours
- Blood levels ~100 nanograms/mL regardless of cannabis potency (self-titration)
- Edibles: 30-90 minute onset, 4-8 hour duration, lower blood levels (2-5 ng/mL)
- Edibles produce 11-hydroxy-THC metabolite, more potent than THC
- Concentrates (dabs) can't be titrated, produce 200-300 ng/mL blood levels
Cannabis Potency and Tolerance
- 1970s cannabis: ~5% THC; modern: 20-30% THC
- People self-regulate to achieve similar blood levels across potencies
- Plant biology limits natural THC to ~25-30% maximum
- Concentrates (90-98% THC) are problematic - can't be titrated
- Tolerance more prominent with high-potency extracts
- Most users don't escalate like other drugs
Cannabis Use Disorder and Addiction
- ~30% of weekly users may develop cannabis use disorder
- Criteria similar to other substance use disorders
- Can consume time/energy, risky behavior for access, relationship/responsibility impacts
- Withdrawal symptoms: irritability when access unavailable
Legalization Effects
- Biggest use increases in elderly populations (especially women 55+)
- Young adult (20-24) use increased
- Teenage use rates remained stable or slightly decreased
- ER visits increased due to:
- Unintentional pediatric edible consumption
- Policy changes making people more likely to seek help
Sativa vs Indica Strains
- Botanical terms referring to plant shape, not chemical composition
- No consistent chemical differences between sativa/indica classifications
- Variability within each category greater than between categories
- Subjective effects likely due to expectancy bias
- No blinded clinical trials demonstrating differential effects
CBD (Cannabidiol)
- Doesn't bind CB1 receptors, no psychoactive effects
- Most street cannabis contains <1% CBD (bred out in favor of THC)
- Clinical efficacy only demonstrated in pediatric epilepsy at very high doses (1500-2000mg)
- Commercial CBD products (2-25mg) likely produce placebo effects
- Poor bioavailability (~4% oral), improved with fatty meals (~20%)
- May work through adenosine transporter inhibition (anti-caffeine effect)
- High doses can saturate liver enzymes, affecting other drug metabolism
THC and Psychosis/Schizophrenia
- Acute cannabis-induced psychotic episodes possible but rare
- Association between cannabis use and schizophrenia development exists
- Correlation vs causation debate:
- Cannabis users have higher schizophrenia rates
- People with schizophrenia use cannabis at higher rates
- Alternative explanation: genetic predisposition to both conditions
- Genetic studies suggest schizophrenia risk predicts cannabis use more than reverse
- Schizophrenia rates stable despite increased cannabis use since 1960s
- Countries with low cannabis use have similar schizophrenia rates
- Cannabis may accelerate onset in predisposed individuals rather than cause denovo
Bipolar and Mental Health
- Similar hereditary patterns between schizophrenia and bipolar
- Limited research on cannabis-bipolar interactions
- Recommendation: avoid cannabis if family history of schizophrenia or bipolar
Cannabis and Anxiety
- Biphasic effects: low doses reduce anxiety, high doses increase anxiety
- 85% of users report using cannabis to reduce stress/anxiety
- Mechanism involves differential effects on excitatory vs inhibitory neurons
- Low doses affect glutamate neurons (anti-anxiety)
- High doses affect GABA neurons (pro-anxiety)
- May help people with naturally low anandamide levels
Medical Applications
- Pain: Most evidence-supported use, strips away emotional component rather than direct analgesia
- Appetite: Effective for cancer patients, tricks brain into "fasting" state
- PTSD: Small studies show nightmare suppression, improves sleep quality
- Glaucoma: Can reduce eye pressure
- Pediatric Epilepsy: CBD highly effective for specific conditions like Dravet syndrome
Health Risks and Harms
- Cardiovascular: Vasodilation causes postural hypotension, compensatory tachycardia
- Potential increased stroke/cardiac event risk in vulnerable populations
- Respiratory: Lung damage from combustion, but lower cancer risk than cigarettes
- Cyclic Vomiting Syndrome: Rare condition in heavy users, treated with hot showers
- Drug Testing: THC stored in fat, detectable 30+ days, exercise can cause re-release
- Driving Impairment: No reliable roadside testing due to complex pharmacokinetics
Hormonal Effects
- Mixed evidence on testosterone/estrogen effects
- Transient testosterone drops reported but within normal ranges
- Prolactin generally suppressed (opposite of some claims)
- Potential sperm quality effects in some individuals
- Pregnancy use: 2-15% prevalence, mostly first trimester before awareness
Memory and Cognitive Effects
- Acute short-term memory impairment during intoxication
- State-dependent learning can develop with regular use
- No compelling evidence for long-term permanent cognitive effects
- Tolerance develops to cognitive impairments
Cannabis and Sleep
- THC helps sleep initiation but alters REM architecture
- REM suppression may be beneficial for PTSD (reduces nightmares)
- Not recommended as general sleep aid due to architecture changes
Future Research Directions
- Need for blinded studies on strain differences
- Entourage effect research with isolated terpenes/cannabinoids
- Better understanding of individual variation in responses
- Genetic factors predicting benefits vs risks
